Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06390111
Status:
RECRUITING
Last Update Posted:
2024-06-28
First Post:
2024-04-19
Brief Title:
A Trial to Evaluate Efficacy of Reinduction With Nadofaragene Firadenovec in Subjects With CIS High-grade TaT1 and no Complete Response to First Nadofaragene Firadenovec Dose
Sponsor:
Ferring Pharmaceuticals
Organization:
Ferring Pharmaceuticals
Conditions & Keywords Data
Conditions:
| Name |
|---|
| CIS |
| Bladder Cancer |
| TaT1 |
Keywords: